By Administrator_ India Capital Sands Ahmedabad-based pharma major Cadila Healthcare (Zydus Cadila) is planning to start clinical trials on children aged 5 years and above soon for its DNA-plasmid technology-based Covid-19 vaccine, claimed a senior official. Meanwhile, the company is awaiting approval from the Drugs Controller General of India (DCGI) for its vaccine ZyCoV-D. It […]